{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:25:07Z","timestamp":1791498307484,"version":"4.3.4"},"reference-count":16,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6332,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1111\/j.1600-0404.1998.tb05956.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T21:28:19Z","timestamp":1233264499000},"page":"300-302","source":"Crossref","is-referenced-by-count":11,"title":["Glutamine synthetase actiity in patients with Parkinson's disease"],"prefix":"10.1155","volume":"97","author":[{"given":"F.","family":"Zipp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Demisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Derouiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutama-tergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease","volume":"13","author":"CARLSSON","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB2","first-page":"10","volume-title":"International workshop Berlin, Parkinson's disease","author":"RlEDERER","year":"1991"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of moement disorders of basal ganglia origin","volume":"13","author":"DELONG","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0006-8993(96)00915-8","article-title":"A postmortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamo-cortical circuits in Parkinson syndrome","volume":"741","author":"GERLACH","year":"1996","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.42.2.402","article-title":"Glutamate receptors in the substantia nigra of Parkinson's disease brains","volume":"42","author":"DIFAZIO","year":"1992","journal-title":"Neurol"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01258633","article-title":"The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice","volume":"75","author":"CARLSSON","year":"1989","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410280411","article-title":"NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats","volume":"28","author":"KLOCKGETHER","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP neurotoxicity by N-methyl-D-aspartate antagonists","volume":"349","author":"TURSKI","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1471-4159.1982.tb03966.x","article-title":"Effects of the conulsant methionine sulfoximine on striatal dopamine metabolism","volume":"39","author":"ROTHSTEIN","year":"1982","journal-title":"J Neurochem"},{"issue":"3","key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcp.1041490315","article-title":"Glutamine synthetase expression in rat oligodendrocytes in culture - regulation by hormones and growth factors","volume":"149","author":"FRESSINAUD","year":"1991","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0022-4731(83)90388-6","article-title":"Presence and steroid inducibility of glutamine synthetase in human leukemic cells","volume":"19","author":"MARCHETTI","year":"1983","journal-title":"J Steroid Biochem"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-8993(91)90103-3","article-title":"Astroglial processes around identified glutamatergic synapses contain glutamine synthetase: eidence for transmitter degradation","volume":"552","author":"DEROUICHE","year":"1991","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3940(94)90739-0","article-title":"Glutamine synthetase immunore-actiity in the human hippocampus is lamina-specific","volume":"165","author":"DEROUICHE","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","article-title":"Aging, energy, and oxidatie stress in neurodegeneratie diseases","volume":"38","author":"BEAL","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB15","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","article-title":"Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease","author":"SMITH","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1111\/j.1600-0404.1998.tb05956.x-BIB16","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/ana.410320706","article-title":"Free radical damage to protein and DNA: mechanisms inoled and releant obserations on brain undergoing oxidatie stress","volume":"32","author":"FLOYD","year":"1992","journal-title":"Ann Neurol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1998.tb05956.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1998.tb05956.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:45:06Z","timestamp":1671540306000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1998.tb05956.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1998.tb05956.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}